3-D-printed drug carrier shows promise; Swiss, South Korean pharma companies sign drug delivery pact;

> South Korean researchers announced positive results from their test of a 3-D-printed drug and cell carrier for local and sustained delivery of cyclosporine A. "The improved load-bearing capacity of the combined microsphere and hydrogel system, and its ability to maintain its integrity and shape during the implantation period, helped to deliver a sustained CsA release, preventing the acceleration of the secretion of cytokines related to immune rejection," said Dr. Dong-Woo Cho of the Department of Mechanical Engineering at Pohang University of Science and Technology. More

> Switzerland's Ferring Pharmaceuticals announced that it has a signed a deal with South Korea's CTCBIO Inc. to acquire the rights to a novel oral drug delivery technology. Release

> Not-for-profit preclinical research institute CBSET said its study found that the use of Cardiovascular Systems' Diamondback 360 orbital atherectomy device improved drug absorption in calcified peripheral arteries. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.